Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.

Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, Cazzato G, Zorzon M.

Neuroepidemiology. 2003 Jan-Feb;22(1):65-74.

PMID:
12566956
2.

Incidence and prevalence of multiple sclerosis in the Americas: a systematic review.

Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, Koch M, Makhani N, Morrow S, Fisk J, Dykeman J, Jetté N, Pringsheim T, Marrie RA.

Neuroepidemiology. 2013;40(3):195-210. doi: 10.1159/000342779. Review.

PMID:
23363936
3.

Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

Koch-Henriksen N, Sorensen PS.

J Neurol Sci. 2011 Dec 15;311(1-2):58-63. doi: 10.1016/j.jns.2011.09.003. Review.

PMID:
21982346
4.

[The organisation of health care and epidemiology of multiple sclerosis in France].

Debouverie M, Rumbach L, Clavelou P.

Rev Neurol (Paris). 2007 Jun;163(6-7):637-45. Review. French.

PMID:
17607182
5.
6.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, Béland SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA.

BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128. Review.

8.

Temporal trends in the incidence of multiple sclerosis: a systematic review.

Alonso A, Hernán MA.

Neurology. 2008 Jul 8;71(2):129-35. doi: 10.1212/01.wnl.0000316802.35974.34. Review.

9.

The changing demographic pattern of multiple sclerosis epidemiology.

Koch-Henriksen N, Sørensen PS.

Lancet Neurol. 2010 May;9(5):520-32. doi: 10.1016/S1474-4422(10)70064-8. Review.

PMID:
20398859
10.

[Multiple sclerosis in Argentina. Systematic review and meta-analysis].

Rojas JI, Patrucco L, Cristiano E.

Medicina (B Aires). 2012;72(6):449-54. Review. Spanish.

11.

Epidemiology of multiple sclerosis in Iran: a systematic review.

Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, Fereidan-Esfahani M.

Eur Neurol. 2013;70(5-6):356-63. doi: 10.1159/000355140. Review.

12.

Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.

Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA.

Neuroepidemiology. 2015;44(4):232-44. doi: 10.1159/000431042. Review.

13.

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Grytten N, Torkildsen Ø, Myhr KM.

Acta Neurol Scand. 2015;132(199):29-36. doi: 10.1111/ane.12428. Review.

14.

Multiple sclerosis in New Zealand.

Alla S, Mason DF.

J Clin Neurosci. 2014 Aug;21(8):1288-91. doi: 10.1016/j.jocn.2013.09.009. Review.

PMID:
24503208
15.

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Marrie RA, Cohen J, Stuve O, Trojano M, Sørensen PS, Reingold S, Cutter G, Reider N.

Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Review.

16.

[Epidemiology of multiple sclerosis. Controversies and realities].

Hernández MA.

Rev Neurol. 2000 May 16-31;30(10):959-64. Review. Spanish.

PMID:
10919195
17.

The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.

Cristiano E, Rojas J, Romano M, Frider N, Machnicki G, Giunta D, Calegaro D, Corona T, Flores J, Gracia F, Macias-Islas M, Correale J.

Mult Scler. 2013 Jun;19(7):844-54. doi: 10.1177/1352458512462918. Review.

PMID:
23045380
18.

The increasing prevalence of multiple sclerosis in New Zealand.

Alla S, Pearson J, Debernard L, Miller D, Mason D.

Neuroepidemiology. 2014;42(3):154-60. doi: 10.1159/000358174. Review.

19.

Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.

Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA.

Psychol Med. 2013 Mar;43(3):471-81. doi: 10.1017/S0033291712001511. Review.

PMID:
22831756
20.

Towards establishing MS prevalence in Latin America and the Caribbean.

Melcon MO, Melcon CM, Bartoloni L, Cristiano E, Duran JC, Grzesiuk AK, Fragoso YD, Brooks JB, Díaz V, Romero García KM, Cabrera Gomez JA, Abad P, Islas MA, Gracia F, Diaz de Bedoya VF, Ruiz ME, Hackembruch JH, Oehninger C, Ketzoian CN, Soto A; Grupo Colaborativo Multicéntrico para el Estudio de la Esclerosis Multiple en America Latina y el Caribe (GEEMAL)..

Mult Scler. 2013 Feb;19(2):145-52. doi: 10.1177/1352458512441985. Review.

PMID:
22492129
Items per page

Supplemental Content

Support Center